These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 18672303

  • 1. Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury.
    Shan X, Xu X, Cao B, Wang Y, Guo L, Zhu Q, Li J, Que L, Chen Q, Ha T, Li C, Li Y.
    Int J Cardiol; 2009 May 29; 134(3):384-92. PubMed ID: 18672303
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia.
    Jun JH, Jun NH, Shim JK, Shin EJ, Kwak YL.
    Eur J Pharmacol; 2014 Dec 15; 745():1-9. PubMed ID: 25446919
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
    Kobayashi H, Miura T, Ishida H, Miki T, Tanno M, Yano T, Sato T, Hotta H, Shimamoto K.
    Clin Exp Pharmacol Physiol; 2008 Jul 15; 35(7):812-9. PubMed ID: 18346168
    [Abstract] [Full Text] [Related]

  • 7. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
    Bullard AJ, Govewalla P, Yellon DM.
    Basic Res Cardiol; 2005 Sep 15; 100(5):397-403. PubMed ID: 15944807
    [Abstract] [Full Text] [Related]

  • 8. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR, Liu HT, Zhang HF, Zhang QJ, Li QX, Yu QJ, Guo WY, Wang HC, Gao F.
    Apoptosis; 2007 Sep 15; 12(9):1579-88. PubMed ID: 17505785
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
    Burger DE, Xiang FL, Hammoud L, Jones DL, Feng Q.
    J Pharmacol Exp Ther; 2009 Jun 15; 329(3):900-7. PubMed ID: 19307451
    [Abstract] [Full Text] [Related]

  • 10. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P, Shi Y, Su J, Pritchard KA, Tweddell JS, Baker JE.
    Basic Res Cardiol; 2005 May 15; 100(3):187-97. PubMed ID: 15611843
    [Abstract] [Full Text] [Related]

  • 11. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
    Tada H, Kagaya Y, Takeda M, Ohta J, Asaumi Y, Satoh K, Ito K, Karibe A, Shirato K, Minegishi N, Shimokawa H.
    Cardiovasc Res; 2006 Aug 01; 71(3):466-77. PubMed ID: 16781691
    [Abstract] [Full Text] [Related]

  • 12. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N, Tamareille S, Ducluzeau PH, Grimaud L, Loufrani L, Croué A, Tourmen Y, Henrion D, Furber A, Prunier F.
    Basic Res Cardiol; 2011 Jan 01; 106(1):147-62. PubMed ID: 20981553
    [Abstract] [Full Text] [Related]

  • 13. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ, Zaman AK, Sobel BE.
    Coron Artery Dis; 2009 Jun 01; 20(4):295-9. PubMed ID: 19440068
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.
    Liu X, Xie W, Liu P, Duan M, Jia Z, Li W, Xu J.
    Life Sci; 2006 Apr 04; 78(19):2255-64. PubMed ID: 16336978
    [Abstract] [Full Text] [Related]

  • 15. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
    Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q.
    Cardiovasc Res; 2006 Oct 01; 72(1):51-9. PubMed ID: 16904088
    [Abstract] [Full Text] [Related]

  • 16. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ, Ding WH, Gao W, Huo Y, Hong T, Zhu RY, Ma DL.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):548-53. PubMed ID: 15144587
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
    Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, Tsakiris D.
    Nephrol Dial Transplant; 2006 Feb 02; 21(2):330-6. PubMed ID: 16221709
    [Abstract] [Full Text] [Related]

  • 18. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM, Jia Z, Zhou ZQ, Xu JG.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 18; 87(35):2463-7. PubMed ID: 18067805
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
    Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium DT, Ma XL, Willette RN, Yue TL.
    Cardiovasc Res; 2004 Feb 15; 61(3):548-58. PubMed ID: 14962485
    [Abstract] [Full Text] [Related]

  • 20. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W, Wu Y, Li G, Cao W, Yang Z, Liu Z.
    Am J Physiol Endocrinol Metab; 2008 Jan 15; 294(1):E183-9. PubMed ID: 18003719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.